Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian S Barnett

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
CNS Drugs|January 17, 2026
Safety and Efficacy of Monoamine Oxidase Inhibitors in Patients Who Use Psychoactive Substances: Potential Drug Interactions and Substance Use Disorder Treatment DataGaëlle Rached, Anna Campana, Dimitri Fiani, et al.
International Journal of Psychiatry in Clinical Practice|December 5, 2019
Risk factors for readmission among a cohort of psychiatric inpatients in Lilongwe, MalawiBrian S Barnett, Veronica Kusunzi, Lucy Magola, et al.
Social Psychiatry and Psychiatric Epidemiology|October 24, 2018
Factors associated with long length of stay in an inpatient psychiatric unit in Lilongwe, MalawiBrian S Barnett, Veronica Kusunzi, Lucy Magola, et al.
Psychedelic Medicine (New Rochelle, N.Y.)|March 7, 2025
American Psychiatrists' Opinions About Classic Hallucinogens and Their Potential Therapeutic Applications: A 7-Year Follow-Up SurveyBrian S Barnett, Miranda Arakelian, David Beebe, et al.
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|July 17, 2023
Methamphetamine-associated catatonia: Case series and systematic review of the literature from 1943-2020Bojan Slavnic, Brian S Barnett, Seth McIntire, et al.
The Primary Care Companion for CNS Disorders|June 26, 2026
Psychological Adverse Effects of Psychedelic UseFranklin King, Juliana Zambrano, Erin Mauney, et al.
The Primary Care Companion for CNS Disorders|June 26, 2026
Medical Complications of PsychedelicsFranklin King, Brian S Barnett, S Trevor Taylor, et al.
Psychiatry Research|March 6, 2025
Patient preference effects in a randomized comparative effectiveness study of electroconvulsive therapy and ketamine for treatment resistant depression: An ELEKT-D trial secondary analysisGerard Sanacora, Brian S Barnett, Bo Hu, et al.
Psychiatry Research|March 27, 2025
The therapeutic effects of psychedelics for opioid use disorder: A systematic review of clinical studiesJeremy Weleff, Alejandra Pulido-Saavedra, Ardavan Mohammad Aghaei, et al.
Psychopharmacology|December 3, 2024
Practical considerations in the establishment of psychedelic research programsBrian S Barnett, M Frances Vest, Marcus S Delatte, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
CNS Drugs|January 17, 2026
Safety and Efficacy of Monoamine Oxidase Inhibitors in Patients Who Use Psychoactive Substances: Potential Drug Interactions and Substance Use Disorder Treatment DataGaëlle Rached, Anna Campana, Dimitri Fiani, et al.
International Journal of Psychiatry in Clinical Practice|December 5, 2019
Risk factors for readmission among a cohort of psychiatric inpatients in Lilongwe, MalawiBrian S Barnett, Veronica Kusunzi, Lucy Magola, et al.
Social Psychiatry and Psychiatric Epidemiology|October 24, 2018
Factors associated with long length of stay in an inpatient psychiatric unit in Lilongwe, MalawiBrian S Barnett, Veronica Kusunzi, Lucy Magola, et al.
Psychedelic Medicine (New Rochelle, N.Y.)|March 7, 2025
American Psychiatrists' Opinions About Classic Hallucinogens and Their Potential Therapeutic Applications: A 7-Year Follow-Up SurveyBrian S Barnett, Miranda Arakelian, David Beebe, et al.
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|July 17, 2023
Methamphetamine-associated catatonia: Case series and systematic review of the literature from 1943-2020Bojan Slavnic, Brian S Barnett, Seth McIntire, et al.
The Primary Care Companion for CNS Disorders|June 26, 2026
Psychological Adverse Effects of Psychedelic UseFranklin King, Juliana Zambrano, Erin Mauney, et al.
The Primary Care Companion for CNS Disorders|June 26, 2026
Medical Complications of PsychedelicsFranklin King, Brian S Barnett, S Trevor Taylor, et al.
Psychiatry Research|March 6, 2025
Patient preference effects in a randomized comparative effectiveness study of electroconvulsive therapy and ketamine for treatment resistant depression: An ELEKT-D trial secondary analysisGerard Sanacora, Brian S Barnett, Bo Hu, et al.
Psychiatry Research|March 27, 2025
The therapeutic effects of psychedelics for opioid use disorder: A systematic review of clinical studiesJeremy Weleff, Alejandra Pulido-Saavedra, Ardavan Mohammad Aghaei, et al.
Psychopharmacology|December 3, 2024
Practical considerations in the establishment of psychedelic research programsBrian S Barnett, M Frances Vest, Marcus S Delatte, et al.
Pageof 6